Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/152526
Full metadata record
DC FieldValueLanguage
dc.creatorDurães, F
dc.creatorSilva, PMA
dc.creatorNovais, P
dc.creatorAmorim, I
dc.creatorGales, L
dc.creatorEsteves, CIC
dc.creatorGuieu, S
dc.creatorBousbaa, H
dc.creatorPinto, M
dc.creatorSousa, E
dc.date.accessioned2023-08-29T08:22:23Z-
dc.date.available2023-08-29T08:22:23Z-
dc.date.issued2021
dc.identifier.issn1420-3049
dc.identifier.urihttps://hdl.handle.net/10216/152526-
dc.description.abstractThioxanthones are bioisosteres of the naturally occurring xanthones. They have been described for multiple activities, including antitumor. As such, the synthesis of a library of thioxanthones was pursued, but unexpectedly, four tetracyclic thioxanthenes with a quinazoline– chromene scaffold were obtained. These compounds were studied for their human tumor cell growth inhibition activity, in the cell lines A375-C5, MCF-7 and NCI-H460. Photophysical studies were also performed. Two of the compounds displayed GI50 values below 10 µM for the three tested cell lines, and structure–activity relationship studies were established. Three compounds presented similar wavelengths of absorption and emission, characteristic of dyes with a push-pull character. The structures of two compounds were elucidated by X-ray crystallography. Two tetracyclic thioxanthenes emerged as hit compounds. One of the two compounds accumulated intracellularly as a bright fluorescent dye in the green channel, as analyzed by both fluorescence microscopy and flow cytometry, making it a promising theranostic cancer drug candidate.
dc.description.sponsorshipThis research was partially supported by the Strategic Funding UIDB/04423/2020, UIDP/04423/2020 (Group of Natural Products and Medicinal Chemistry‐CIIMAR) and under the project PTDC/SAU‐PUB/28736/2017 (reference POCI‐01‐0145‐FEDER‐028736), co‐financed by COMPETE 2020, Portugal 2020 and the European Union through the ERDF and by FCT through national funds. Fernando Durães acknowledges his FCT grant (SFRH/BD/144681/2019). Hassan Bousbaa acknowledges funding from CESPU (IMPLDEBRIS‐PL‐3RL‐IINFACTS‐2019). This research was funded by Fundação para a Ciência e a Tecnologia (FCT) through research units UIDB/50006/2020, UID/CTM/50011/2019, UIDB/50011/2020 & UIDP/50011/2020 and by the European Union (FEDER program) through project CENTRO‐01‐0145‐FEDER‐000003.
dc.language.isoeng
dc.publisherMDPI
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04423%2F2020/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04423%2F2020/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FSAU-PUB%2F28736%2F2017/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F144681%2F2019/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FCTM%2F50011%2F2019/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50011%2F2020/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50011%2F2020/PT
dc.relation.ispartofMolecules, vol.26(11):3315
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectAntitumor activity
dc.subjectPhotophysics
dc.subjectTheranostic
dc.subjectThioxanthenes
dc.titleTetracyclic thioxanthene derivatives: Studies on fluorescence and antitumor activity
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/molecules26113315
dc.relation.publisherversionhttps://www.mdpi.com/1420-3049/26/11/3315
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-molecules26113315.pdf2.83 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons